Literature DB >> 19521972

Cognitive adaptation training for outpatients with schizophrenia.

Meredith L Draper1, Donna S Stutes, Natalie J Maples, Dawn I Velligan.   

Abstract

Schizophrenia is a complex neurodevelopmental disorder characterized by cognitive deficits. These deficits in cognitive functioning have been shown to relate to a variety of functional and treatment outcomes. Cognitive adaptation training (CAT) is a home-based, manual-driven treatment that utilizes environmental supports and compensatory strategies to bypass cognitive deficits and improve target behaviors and functional outcomes in individuals with schizophrenia. Unlike traditional case management, CAT provides environmental supports and compensatory strategies tailored to meet the behavioral style and neurocognitive deficits of each individual patient. The case of Ms. L. is presented to illustrate CAT treatment.

Entities:  

Mesh:

Year:  2009        PMID: 19521972     DOI: 10.1002/jclp.20612

Source DB:  PubMed          Journal:  J Clin Psychol        ISSN: 0021-9762


  8 in total

1.  Conceptualization and treatment of negative symptoms in schizophrenia.

Authors:  Sonali Sarkar; Kiley Hillner; Dawn I Velligan
Journal:  World J Psychiatry       Date:  2015-12-22

2.  Probable mechanisms involved in the antipsychotic-like activity of methyl jasmonate in mice.

Authors:  Olajide S Annafi; Oritoke M Aluko; Anthony T Eduviere; Osarume Omorogbe; Solomon Umukoro
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-06-13       Impact factor: 3.000

3.  Transition Experiences Following Psychiatric Hospitalization: A systematic Review of the Literature.

Authors:  Christina Mutschler; Sidney Lichtenstein; Sean A Kidd; Larry Davidson
Journal:  Community Ment Health J       Date:  2019-05-18

4.  The feasibility of cognitive adaptation training for outpatients with schizophrenia in integrated treatment.

Authors:  Jens Peter Hansen; Birte Østergaard; Merete Nordentoft; Lise Hounsgaard
Journal:  Community Ment Health J       Date:  2012-10-12

5.  Cognitive remediation in schizophrenia.

Authors:  Yoshio Kaneko; Matcheri Keshavan
Journal:  Clin Psychopharmacol Neurosci       Date:  2012-12-20       Impact factor: 2.582

6.  Methyl Jasmonate: Behavioral and Molecular Implications in Neurological Disorders.

Authors:  Oritoke Modupe Aluko; Joy Dubem Iroegbu; Omamuyovwi Meashack Ijomone; Solomon Umukoro
Journal:  Clin Psychopharmacol Neurosci       Date:  2021-05-31       Impact factor: 2.582

7.  Antipsychotic-like effect of ethyl acetate fraction of Terminalia macroptera leaf in mice.

Authors:  Lydia Doosuur Ior; Sunday Oritsetimenyin Otimenyin; Francis Kanayo Okwuasaba
Journal:  IBRO Neurosci Rep       Date:  2021-01-22

8.  Feasibility of PRIME: A Cognitive Neuroscience-Informed Mobile App Intervention to Enhance Motivated Behavior and Improve Quality of Life in Recent Onset Schizophrenia.

Authors:  Danielle Schlosser; Timothy Campellone; Daniel Kim; Brandy Truong; Silvia Vergani; Charlie Ward; Sophia Vinogradov
Journal:  JMIR Res Protoc       Date:  2016-04-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.